世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

皮膚科向け機器の市場：タイプ（診断機器（皮膚鏡、画像診断機器）、治療機器（レーザー、凍結療法、脂肪吸引）、用途（皮膚がん、にきび、乾癬、肌の若返り、入れ墨除去）別 - 2027年までの世界市場予測


Dermatology Devices Market by Type (Diagnostic Devices (Dermatoscopes, Imaging Devices), Treatment Devices (Laser, Cryotherapy, Liposuction), Application (Skin Cancer, Acne, Psoriasis, Skin Rejuvenation, Tattoo Removal) - Global Forecast to 2027

皮膚科機器の世界市場は、2022年の62億米ドルから2027年には113億米ドルに達すると予測され、予測期間中のCAGRは12.7%です。皮膚科用機器は、皮膚科医や外科医が皮膚疾患を診断・治療する際に役立ちます。これら... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2022年6月29日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		242 244 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

皮膚科機器の世界市場は、2022年の62億米ドルから2027年には113億米ドルに達すると予測され、予測期間中のCAGRは12.7%です。皮膚科用機器は、皮膚科医や外科医が皮膚疾患を診断・治療する際に役立ちます。これらの機器は、病院、皮膚科クリニック、医院、学術研究機関など、さまざまな医療機関で使用されています。皮膚疾患の発生率の上昇と美容整形に対する意識の高まりが、皮膚科機器市場の主な成長要因となっています。また、発展途上地域における医療インフラの拡充は、同市場で活動するプレイヤーに成長機会を提供するものと期待されています。

"2021年、皮膚科診断機器市場のタイプ別シェアは画像診断機器が最大となる見込み"
皮膚科診断機器市場は、タイプ別に、イメージングデバイス、皮膚鏡、顕微鏡に分類されます。2021年の皮膚科診断機器市場では、画像診断機器セグメントが最も大きなシェアを占めています。このセグメントの大きなシェアは、技術的な進歩や皮膚疾患の発生率の増加によるものであると考えられる。

"2021年の皮膚科診断機器市場の用途別シェアは、皮膚がん診断が最大を占める。"
皮膚科診断機器市場は、用途に基づき、皮膚がん診断とその他の診断用途に区分されます。2021年には、皮膚がん診断分野が最も大きなシェアを占めています。このセグメントの大きなシェアは、皮膚がんの発生率の上昇に起因するものである。

"アジア太平洋地域は、予測期間中に皮膚科機器の最高のCAGRを命じた。"
地域別に見ると、皮膚科機器市場は、北米、欧州、アジア太平洋、その他の地域に区分されます。予測期間中、アジア太平洋地域は皮膚科機器市場のCAGRが最も高くなっています。この地域区分のCAGRが最も高いのは、人口の多さ、生活水準の向上、質の高い医療への需要の高まり、医療支出の増加、政府の取り組み、皮膚科機器に関する認知度の向上などの要因によるものです。

供給側の一次面接の内訳、企業タイプ別、呼称別、地域別。
- 企業タイプ別企業タイプ別：Tier1 (20%)、Tier2 (45%)、Tier3 (35%)
- 役職別Cレベルエグゼクティブ(30%)、ディレクター(20%)、その他(50%)
- 地域別北米 (33%)、欧州 (24%)、アジア太平洋 (27%)、その他の地域 (16%)

主な参入企業 Lumenis Ltd.（イスラエル）、Alma Las.(イスラエル）、Alma Lasers, Ltd.（米国）、Solta Medical（米国）、Cutera, Inc.

報告書に掲載されている企業一覧
- アルマ・レーザー社（Alma Lasers, Ltd.(イスラエル)
- Cutera, Inc.(米国)
- シノシュア社（米国）
- El.En.S.P.A.（イタリア）
- Lumenis Ltd.(イスラエル)
- ソルタメディカル (アメリカ)
- ブルカーコーポレーション（アメリカ）
- カールツァイス (ドイツ)
- ハイネオプトテクニックGmbH & Co.KG (ドイツ)
- マイケルソン・ダイアグノスティックス社（英国(イギリス)
- PhotoMedex, Inc.（米国）
- ライカマイクロシステムズ (米国)
- オリンパス株式会社（日本）
- シナロン・メディカル・リミテッド(米国)
- ジェネシス バイオシステムズ社（米国）
- キャンフィールドサイエンティフィック社（米国）
- キャンデラ社（米国）
- DermLite（米国）
- 北京トップレーザーテクノロジー社（中国(中国)
- Aerolase（米国）
- FotoFinder Systems GmbH（ドイツ）
- ボビー（米国）
調査対象
本レポートでは、皮膚科機器市場をタイプ、アプリケーション、地域に基づいて調査しています。また、市場成長に影響を与える要因（促進要因、阻害要因、課題、機会など）を分析しています。利害関係者向けに市場の機会や課題を評価し、市場リーダー向けに競争環境の詳細を提供しています。また、マイクロマーケットについては、その成長動向、展望、皮膚科機器市場全体への貢献度に関して調査しています。本レポートでは、4つの主要地域に関して、市場セグメントの収益を予測しています。

レポート購入の理由
本レポートは、以下のポイントに関する洞察を提供しています。

- 市場の浸透。内視鏡再処理市場の上位22社が提供する皮膚科用機器に関する包括的な情報です。このレポートでは、皮膚科用デバイスの市場タイプ、アプリケーション、地域を分析します。

- 市場の発展。有利な新興市場に関する包括的な情報を提供します。本レポートでは、主要地域ごとの各種固定装置市場を分析しています。

- 市場の多様化。皮膚科機器市場における新製品、未開拓の地域、最近の開発、投資に関する徹底的な情報を提供します。

- 競争力のある評価。皮膚科機器市場における主要企業の市場シェアと戦略に関する詳細な評価

ページTOPに戻る


目次

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS AND EXCLUSIONS 30
1.3 MARKET SCOPE 31
1.3.1 MARKET SEGMENTATION 31
1.3.2 GEOGRAPHIC SCOPE 32
1.3.3 YEARS CONSIDERED 32
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 37
FIGURE 2 PRIMARY SOURCES 37
2.1.2.1 Key data from primary sources 38
2.1.2.2 Key industry insights 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 41
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION 41
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY TREATMENT DEVICES 42
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY DIAGNOSTIC DEVICES 42
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
FIGURE 9 TOP-DOWN APPROACH 44
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 45
FIGURE 10 DATA TRIANGULATION METHODOLOGY 45
2.4 MARKET SHARE ANALYSIS 46
2.5 STUDY ASSUMPTIONS 46
2.6 RISK ASSESSMENT/FACTOR ANALYSIS 47
TABLE 1 RISK ANALYSIS 47
3 EXECUTIVE SUMMARY 48
FIGURE 11 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 12 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 49
FIGURE 13 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 14 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 15 DERMATOLOGY DEVICES MARKET, BY REGION,
2022 VS. 2027 (USD MILLION) 51
4 PREMIUM INSIGHTS 52
4.1 DERMATOLOGY DEVICES MARKET OVERVIEW 52
FIGURE 16 RISING INCIDENCE OF SKIN DISEASES TO DRIVE MARKET GROWTH 52
4.2 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE (2021) 52
FIGURE 17 IMAGING DEVICES SEGMENT DOMINATED APAC MARKET IN 2021 52
4.3 GEOGRAPHICAL SNAPSHOT OF DERMATOLOGY DEVICES MARKET 53
FIGURE 18 JAPAN TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 19 DERMATOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.2.1 DRIVERS 55
5.2.1.1 Rising incidence of skin disorders 55
5.2.1.2 Availability of technologically advanced and user-friendly products 55
5.2.1.3 Growing adoption of minimally invasive and non-invasive aesthetic procedures 56
5.2.1.4 Rising adoption of aesthetic procedures among geriatric individuals 56
FIGURE 20 INCREASE IN GERIATRIC POPULATION, BY COUNTRY
(2011 VS. 2015 VS. 2030) 57
FIGURE 21 INCREASE IN PROPORTION OF GERIATRIC INDIVIDUALS IN OVERALL POPULATION, BY COUNTRY (2011 VS. 2015 VS. 2030) 57
5.2.1.5 Increasing investments, funds, and grants by public-private organizations 57
TABLE 2 KEY INVESTMENTS BY GOVERNMENT BODIES IN THE DIAGNOSTIC IMAGING MARKET 58
5.2.2 RESTRAINTS 59
5.2.2.1 Stringent regulatory policies for medical devices 59
5.2.2.2 Clinical risks and complications associated with dermatology procedures 59
5.2.2.3 High cost of diagnostic imaging systems 59
5.2.2.4 Declining reimbursements and increasing regulatory
burden in the US 60
TABLE 3 MEDICARE REIMBURSEMENT TRENDS, BY IMAGING MODALITY, 2007–2019 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growing medical devices industry in emerging economies 61
FIGURE 22 MEDICAL DEVICES MARKET, 2016–2020 (USD BILLION) 61
5.2.3.2 Increasing disposable income and expanding middle-class population 61
5.2.4 CHALLENGES 62
5.2.4.1 Competitive pricing by low-cost manufacturers and availability of low-cost substitutes 62
5.2.4.2 Dearth of trained professionals 62
5.2.5 TRENDS 63
5.2.5.1 Importance of artificial intelligence and teleradiology in skin disorder diagnosis and treatment 63
5.3 COVID-19 IMPACT ANALYSIS 63
5.4 RANGES/SCENARIOS 64
5.4.1 DERMATOLOGY DEVICES MARKET 64
FIGURE 23 REALISTIC SCENARIO 64
FIGURE 24 PESSIMISTIC SCENARIO 65
FIGURE 25 OPTIMISTIC SCENARIO 65
5.5 REGULATORY ANALYSIS 66
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING DERMATOLOGY DEVICES 66
5.5.1 NORTH AMERICA 66
5.5.1.1 US 66
TABLE 5 US FDA MEDICAL DEVICE CLASSIFICATION 67
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67
5.5.1.2 Canada 68
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68
5.5.2 EUROPE 68
5.5.3 ASIA PACIFIC 68
5.5.3.1 Japan 68
TABLE 8 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY 69
5.5.3.2 China 69
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 69
5.5.3.3 India 70
5.6 PORTER’S FIVE FORCES ANALYSIS 71
5.6.1 THREAT OF NEW ENTRANTS 72
5.6.2 THREAT OF SUBSTITUTES 72
5.6.3 BARGAINING POWER OF SUPPLIERS 72
5.6.4 BARGAINING POWER OF BUYERS 72
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 72
5.7 SUPPLY CHAIN ANALYSIS 73
FIGURE 26 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES 73
5.8 VALUE CHAIN ANALYSIS 74
FIGURE 27 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 74
5.9 ECOSYSTEM ANALYSIS 75
FIGURE 28 DERMATOLOGY DEVICES MARKET: ECOSYSTEM ANALYSIS 75
5.9.1 ROLE IN ECOSYSTEM 75
FIGURE 29 KEY PLAYERS IN DERMATOLOGY DEVICES MARKET ECOSYSTEM 76
5.10 TECHNOLOGY ANALYSIS 76
5.11 KEY CONFERENCES & EVENTS IN 2022–2023 77
TABLE 10 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF
CONFERENCES & EVENTS 77
5.12 PATENT ANALYSIS 82
5.12.1 PATENT TRENDS FOR DERMATOLOGY DEVICES 82
FIGURE 30 PATENT TRENDS FOR DERMATOSCOPES, JANUARY 2011–JUNE 2022 82
FIGURE 31 PATENT TRENDS FOR LIPOSUCTION DEVICES, JANUARY 2011–JUNE 2022 83
5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS 83
FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS)
FOR DERMATOSCOPE PATENTS, JANUARY 2011—JUNE 2022 84
FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS)
FOR LIPOSUCTION DEVICE PATENTS, JANUARY 2011—JUNE 2022 84
5.13 TRADE ANALYSIS 85
TABLE 11 IMPORT DATA FOR HS CODE 901320, BY COUNTRY,
2017–2021 (USD MILLION) 85
TABLE 12 EXPORT DATA FOR HS CODE 901320, BY COUNTRY,
2017–2021 (USD MILLION) 85
5.14 PRICING ANALYSIS 86
TABLE 13 AVERAGE SELLING PRICES OF DERMATOLOGY DEVICES 86
TABLE 14 COST OF DERMATOLOGY TREATMENT DEVICES 86
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 90
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
FIGURE 34 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES 90
TABLE 15 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES (%) 90
5.15.2 BUYING CRITERIA 91
FIGURE 35 KEY BUYING CRITERIA FOR END USERS OF
DERMATOLOGY TREATMENT DEVICES 91
TABLE 16 KEY BUYING CRITERIA FOR END USERS OF
DERMATOLOGY TREATMENT DEVICES 91
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS 92
5.16.1 REVENUE SHIFT & REVENUE POCKETS FOR DERMATOLOGY DEVICE MANUFACTURERS 92
FIGURE 36 REVENUE SHIFT FOR DERMATOLOGY DEVICES 92
6 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE 93
6.1 INTRODUCTION 94
TABLE 17 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 94
6.2 IMAGING DEVICES 94
6.2.1 MRI, ULTRASOUND, CT, AND OCT ARE WIDELY USED IN DERMATOLOGY DISEASE DIAGNOSIS 94
TABLE 18 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR IMAGING DEVICES,
BY REGION, 2020–2027 (USD MILLION) 95
6.3 DERMATOSCOPES 95
6.3.1 INCREASING AWARENESS ABOUT SKIN HEALTH TO DRIVE SEGMENT GROWTH 95
TABLE 19 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR DERMATOSCOPES,
BY REGION, 2020–2027 (USD MILLION) 96
6.4 MICROSCOPES 96
6.4.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED MICROSCOPES —
A KEY FACTOR DRIVING SEGMENT GROWTH 96
TABLE 20 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR MICROSCOPES,
BY REGION, 2020–2027 (USD MILLION) 97
7 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION 98
7.1 INTRODUCTION 99
TABLE 21 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 99
7.2 SKIN CANCER DIAGNOSIS 99
7.2.1 RISING PREVALENCE OF SKIN CANCER AND INCREASING AWARENESS ABOUT EARLY DIAGNOSIS TO DRIVE SEGMENT GROWTH 99
TABLE 22 NUMBER OF MELANOMA SKIN CANCER CASES, BY COUNTRY (2020) 100
TABLE 23 NUMBER OF NON-MELANOMA SKIN CANCER CASES, BY COUNTRY (2020) 100
TABLE 24 NUMBER OF MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020) 101
TABLE 25 NUMBER OF NON-MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020) 101
TABLE 26 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR SKIN CANCER DIAGNOSIS, BY REGION, 2020–2027 (USD MILLION) 102
7.3 OTHER DIAGNOSTIC APPLICATIONS 102
TABLE 27 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 102
8 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE 103
8.1 INTRODUCTION 104
TABLE 28 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 104
8.2 LIGHT THERAPY DEVICES 104
8.2.1 INCREASING DEMAND FOR SKIN REJUVENATION PROCEDURES
TO DRIVE SEGMENT GROWTH 104
TABLE 29 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIGHT THERAPY DEVICES, BY REGION, 2020–2027 (USD MILLION) 105
8.3 LASERS 105
8.3.1 IMPROVING LASER TECHNOLOGY HAS REVOLUTIONIZED TREATMENTS FOR SEVERAL SKIN CONDITIONS 105
TABLE 30 DERMATOLOGY TREATMENT DEVICES MARKET FOR LASERS, BY REGION, 2020–2027 (USD MILLION) 106
8.4 ELECTROSURGICAL EQUIPMENT 106
8.4.1 RISK OF ELECTROSURGICAL BURNS IS EXPECTED TO HINDER SEGMENT GROWTH 106
TABLE 31 DERMATOLOGY TREATMENT DEVICES MARKET FOR ELECTROSURGICAL EQUIPMENT, BY REGION, 2020–2027 (USD MILLION) 107
8.5 LIPOSUCTION DEVICES 107
8.5.1 INCREASING OBESITY RATES TO DRIVE SEGMENT GROWTH 107
TABLE 32 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIPOSUCTION DEVICES, BY REGION, 2020–2027 (USD MILLION) 107
8.6 MICRODERMABRASION DEVICES 108
8.6.1 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH 108
TABLE 33 DERMATOLOGY TREATMENT DEVICES MARKET FOR MICRODERMABRASION DEVICES, BY REGION, 2020–2027 (USD MILLION) 108
8.7 CRYOTHERAPY DEVICES 108
8.7.1 COST-EFFECTIVE NATURE OF CRYOTHERAPY TO DRIVE ITS ADOPTION 108
TABLE 34 DERMATOLOGY TREATMENT DEVICES MARKET FOR CRYOTHERAPY DEVICES, BY REGION, 2020–2027 (USD MILLION) 109
9 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION 110
9.1 INTRODUCTION 111
TABLE 35 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 111
9.2 HAIR REMOVAL 111
9.2.1 IPL, DIODE, ND:YAG, AND RUBY LASERS ARE WIDELY USED IN HAIR REMOVAL PROCEDURES 111
TABLE 36 LASER HAIR REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020) 112
TABLE 37 DERMATOLOGY TREATMENT DEVICES MARKET FOR HAIR REMOVAL,
BY REGION, 2020–2027 (USD MILLION) 112
9.3 SKIN REJUVENATION 112
9.3.1 GROWING DEMAND FOR SAFE AND EFFECTIVE SKIN REJUVENATION TREATMENTS TO PROPEL SEGMENT GROWTH 112
TABLE 38 DERMATOLOGY TREATMENT DEVICES MARKET FOR SKIN REJUVENATION,
BY REGION, 2020–2027 (USD MILLION) 113
9.4 ACNE, PSORIASIS, AND TATTOO REMOVAL 113
9.4.1 EMERGENCE OF LASER TECHNOLOGY FOR TATTOO REMOVAL TO DRIVE SEGMENT GROWTH 113
TABLE 39 LASER TATTOO REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020) 114
TABLE 40 DERMATOLOGY TREATMENT DEVICES MARKET FOR ACNE, PSORIASIS, AND TATTOO REMOVAL, BY REGION, 2020–2027 (USD MILLION) 114
9.5 WRINKLE REMOVAL AND SKIN RESURFACING 115
9.5.1 RAPIDLY GROWING AGING POPULATION TO DRIVE SEGMENT GROWTH 115
TABLE 41 SKIN RESURFACING PROCEDURES: REGIONAL DISTRIBUTION (2020) 115
TABLE 42 DERMATOLOGY TREATMENT DEVICES MARKET FOR WRINKLE REMOVAL AND SKIN RESURFACING, BY REGION, 2020–2027 (USD MILLION) 116
9.6 BODY CONTOURING AND FAT REMOVAL 116
9.6.1 RISING AWARENESS OF RECONSTRUCTIVE SURGERY
TO DRIVE SEGMENT GROWTH 116
TABLE 43 LIPOSUCTION PROCEDURES: REGIONAL DISTRIBUTION (2020) 117
TABLE 44 NON-INVASIVE FAT REDUCTION (COOLSCULPTING, LIPOSONIX, EMSCULPT, VANQUISH, AND ZERONA) PROCEDURES: REGIONAL DISTRIBUTION (2020) 117
TABLE 45 DERMATOLOGY TREATMENT DEVICES MARKET FOR BODY CONTOURING AND FAT REMOVAL, BY REGION, 2020–2027 (USD MILLION) 118
9.7 VASCULAR AND PIGMENTED LESION REMOVAL 118
9.7.1 EMERGENCE OF LASER TECHNOLOGY FOR VASCULAR LESION REMOVAL TO DRIVE SEGMENT GROWTH 118
TABLE 46 DERMATOLOGY TREATMENT DEVICES MARKET FOR VASCULAR AND PIGMENTED LESION REMOVAL, BY REGION, 2020–2027 (USD MILLION) 118
9.8 WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT 119
9.8.1 CRYOTHERAPY IS WIDELY USED IN WART AND SKIN TAG TREATMENT 119
TABLE 47 DERMATOLOGY TREATMENT DEVICES MARKET FOR WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT, BY REGION, 2020–2027 (USD MILLION) 119
9.9 OTHER TREATMENT APPLICATIONS 119
TABLE 48 DERMATOLOGY TREATMENT DEVICES MARKET FOR OTHER APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION) 119
10 DERMATOLOGY DEVICES MARKET, BY REGION 120
10.1 INTRODUCTION 121
TABLE 49 DERMATOLOGY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 121
10.2 NORTH AMERICA 121
FIGURE 37 NORTH AMERICA: DERMATOLOGY DEVICES MARKET SNAPSHOT 122
TABLE 50 NORTH AMERICA: DERMATOLOGY DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 123
TABLE 51 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 52 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 53 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 54 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 124
10.2.1 US 124
10.2.1.1 US dominated North American market in 2021 124
TABLE 55 US: KEY MACROINDICATORS 125
TABLE 56 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 125
TABLE 57 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 125
TABLE 58 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 126
TABLE 59 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 126
TABLE 60 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 126
TABLE 61 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 62 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 127
TABLE 63 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 127
10.2.2 CANADA 128
10.2.2.1 Technological advancements in dermatology devices to drive market growth in Canada 128
TABLE 64 CANADA: KEY MACROINDICATORS 128
TABLE 65 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 66 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 67 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 129
TABLE 68 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 129
10.3 EUROPE 130
TABLE 69 EUROPE: DERMATOLOGY DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 130
TABLE 70 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 71 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 131
TABLE 72 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 73 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
10.3.1 FRANCE 132
10.3.1.1 Laws in France regarding cosmetic surgery are restrictive as compared with those in other countries 132
TABLE 74 FRANCE: KEY MACROINDICATORS 132
TABLE 75 FRANCE: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 132
TABLE 76 FRANCE: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 133
TABLE 77 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 133
TABLE 78 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 133
TABLE 79 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 134
TABLE 80 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 134
10.3.2 GERMANY 134
10.3.2.1 Rising disposable income to drive dermatology device adoption in Germany 134
TABLE 81 GERMANY: KEY MACROINDICATORS 135
TABLE 82 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 135
TABLE 83 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 135
TABLE 84 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 136
TABLE 85 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 136
TABLE 86 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 136
TABLE 87 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 137
TABLE 88 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 137
TABLE 89 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 137
10.3.3 UK 138
10.3.3.1 Increasing focus on facial dermatology to aid market growth 138
TABLE 90 UK: KEY MACROINDICATORS 138
TABLE 91 UK: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 138
TABLE 92 UK: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 138
TABLE 93 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 139
TABLE 94 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 139
TABLE 95 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 139
TABLE 96 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 140
10.3.4 ITALY 140
10.3.4.1 Rising number of plastic surgeons to drive market growth 140
TABLE 97 ITALY: KEY MACROINDICATORS 140
TABLE 98 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 141
TABLE 99 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 141
TABLE 100 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 141
TABLE 101 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 141
TABLE 102 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 142
TABLE 103 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 142
TABLE 104 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 105 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 143
10.3.5 SPAIN 143
10.3.5.1 Growing demand for cosmetic procedures to drive market growth 143
TABLE 106 SPAIN: KEY MACROINDICATORS 144
TABLE 107 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 144
TABLE 108 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 144
TABLE 109 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 145
TABLE 110 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 145
TABLE 111 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 145
TABLE 112 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 146
TABLE 113 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 146
TABLE 114 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147
10.3.6 REST OF EUROPE 147
TABLE 115 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP) 148
TABLE 116 RUSSIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 148
TABLE 117 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 118 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 119 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 149
TABLE 120 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 150
10.4 ASIA PACIFIC 150
FIGURE 38 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET SNAPSHOT 151
TABLE 121 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 152
TABLE 122 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 123 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 124 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 153
TABLE 125 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 153
10.4.1 JAPAN 153
10.4.1.1 Japan accounted for largest share of APAC market in 2021 153
TABLE 126 JAPAN: KEY MACROINDICATORS 154
TABLE 127 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 154
TABLE 128 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 154
TABLE 129 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 155
TABLE 130 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 155
TABLE 131 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 155
TABLE 132 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 156
TABLE 133 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 156
TABLE 134 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 156
10.4.2 CHINA 157
10.4.2.1 Rising healthcare expenditure to drive market growth in China 157
TABLE 135 CHINA: KEY MACROINDICATORS 157
TABLE 136 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 137 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 158
TABLE 138 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 139 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
10.4.3 INDIA 159
10.4.3.1 Improving healthcare infrastructure to drive market growth in India 159
TABLE 140 INDIA: KEY MACROINDICATORS 159
TABLE 141 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 159
TABLE 142 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 160
TABLE 143 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 160
TABLE 144 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 160
TABLE 145 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 146 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 147 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 161
TABLE 148 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
10.4.4 REST OF ASIA PACIFIC 162
TABLE 149 THAILAND: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 163
TABLE 150 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 163
TABLE 151 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 163
TABLE 152 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 164
TABLE 153 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 164
10.5 REST OF THE WORLD 164
TABLE 154 MEXICO: KEY MACROINDICATORS 165
TABLE 155 BRAZIL: KEY MACROINDICATORS 165
TABLE 156 BRAZIL: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 165
TABLE 157 MEXICO: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 165
TABLE 158 ROW: DERMATOLOGY DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 166
TABLE 159 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 166
TABLE 160 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 166
TABLE 161 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 167
TABLE 162 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 167
11 COMPETITIVE LANDSCAPE 168
11.1 OVERVIEW 168
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 168
TABLE 163 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS 168
11.3 REVENUE ANALYSIS 170
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN DERMATOLOGY TREATMENT DEVICES MARKET 170
11.4 MARKET SHARE ANALYSIS 170
FIGURE 40 DERMATOLOGY TREATMENT DEVICES MARKET SHARE ANALYSIS, 2020 171
TABLE 164 DERMATOLOGY TREATMENT DEVICES MARKET: DEGREE OF COMPETITION 171
11.5 COMPANY EVALUATION MATRIX (KEY PLAYERS) 172
11.5.1 STARS 172
11.5.2 EMERGING LEADERS 172
11.5.3 PARTICIPANTS 173
11.5.4 PERVASIVE PLAYERS 173
FIGURE 41 GLOBAL DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 173
11.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES) 174
11.6.1 PROGRESSIVE COMPANIES 174
11.6.2 STARTING BLOCKS 174
11.6.3 RESPONSIVE COMPANIES 174
11.6.4 DYNAMIC COMPANIES 174
FIGURE 42 DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2021 175
11.7 COMPETITIVE BENCHMARKING 176
TABLE 165 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF KEY SMES/START-UPS 176
TABLE 166 DERMATOLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF SMES/START-UPS 177
11.8 COMPANY FOOTPRINT 177
TABLE 167 OVERALL FOOTPRINT OF COMPANIES 178
TABLE 168 PRODUCT FOOTPRINT OF COMPANIES 179
TABLE 169 REGIONAL FOOTPRINT OF COMPANIES 180
11.9 COMPETITIVE SCENARIO AND TRENDS 181
11.9.1 DEALS 181
TABLE 170 DEALS, JANUARY 2019–MAY 2022 181
11.9.2 PRODUCT LAUNCHES & APPROVALS 182
TABLE 171 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MAY 2022 182
11.9.3 EXPANSIONS 184
TABLE 172 EXPANSIONS, JANUARY 2019–MAY 2022 184
12 COMPANY PROFILES 185
12.1 KEY PLAYERS 185
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 ALMA LASERS, LTD. (A SUBSIDIARY OF SISRAM MEDICAL LTD.) 185
TABLE 173 ALMA LASERS, LTD.: BUSINESS OVERVIEW 185
FIGURE 43 SISRAM MEDICAL LTD.: COMPANY SNAPSHOT (2021) 186
12.1.2 CUTERA, INC. 191
TABLE 174 CUTERA, INC.: BUSINESS OVERVIEW 191
FIGURE 44 CUTERA, INC.: COMPANY SNAPSHOT (2021) 192
12.1.3 CYNOSURE, INC. 196
TABLE 175 CYNOSURE, INC.: BUSINESS OVERVIEW 196
12.1.4 EL.EN. S.P.A. 199
TABLE 176 EL.EN. S.P.A.: BUSINESS OVERVIEW 199
FIGURE 45 EL.EN. S.P.A.: COMPANY SNAPSHOT (2021) 200
12.1.5 LUMENIS, LTD. (A SUBSIDIARY OF BOSTON SCIENTIFIC) 203
TABLE 177 LUMENIS, LTD.: BUSINESS OVERVIEW 203
FIGURE 46 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2021) 204
12.1.6 SOLTA MEDICAL (A SUBSIDIARY OF BAUSCH HEALTH COMPANIES INC.) 208
TABLE 178 SOLTA MEDICAL: BUSINESS OVERVIEW 208
FIGURE 47 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2021) 209
12.1.7 DERMLITE 212
TABLE 179 DERMLITE: BUSINESS OVERVIEW 212
12.1.8 BRUKER CORPORATION 213
TABLE 180 BRUKER CORPORATION: BUSINESS OVERVIEW 213
FIGURE 48 BRUKER CORPORATION: COMPANY SNAPSHOT (2021) 214
12.1.9 CARL ZEISS 215
TABLE 181 CARL ZEISS: BUSINESS OVERVIEW 215
FIGURE 49 CARL ZEISS: COMPANY SNAPSHOT (2021) 216
12.1.10 GENESIS BIOSYSTEMS, INC. 218
TABLE 182 GENESIS BIOSYSTEMS, INC.: BUSINESS OVERVIEW 218
12.1.11 HEINE OPTOTECHNIK GMBH & CO. KG 219
TABLE 183 HEINE OPTOTECHNIK GMBH & CO. KG: BUSINESS OVERVIEW 219
12.1.12 MICHELSON DIAGNOSTICS, LTD. 221
TABLE 184 MICHELSON DIAGNOSTICS, LTD.: BUSINESS OVERVIEW 221
12.1.13 PHOTOMEDEX, INC. (A SUBSIDIARY OF DS HEALTHCARE GROUP) 223
TABLE 185 PHOTOMEDEX, INC.: BUSINESS OVERVIEW 223
12.1.14 FOTOFINDER SYSTEMS GMBH 224
TABLE 186 FOTOFINDER SYSTEMS GMBH: BUSINESS OVERVIEW 224
12.1.15 LEICA MICROSYSTEMS (A SUBSIDIARY OF DANAHER CORPORATION) 225
TABLE 187 LEICA MICROSYSTEMS: BUSINESS OVERVIEW 225
FIGURE 50 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 226
12.1.16 OLYMPUS CORPORATION 228
TABLE 188 OLYMPUS CORPORATION: BUSINESS OVERVIEW 228
FIGURE 51 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021) 229
12.1.17 CANDELA CORPORATION 231
TABLE 189 CANDELA CORPORATION: BUSINESS OVERVIEW 231
FIGURE 52 CANDELA CORPORATION: COMPANY SNAPSHOT (2020) 231
12.1.18 CANFIELD SCIENTIFIC, INC. 235
TABLE 190 CANFIELD SCIENTIFIC, INC.: BUSINESS OVERVIEW 235
12.1.19 BEIJING TOPLASER TECHNOLOGY CO., LTD. 237
TABLE 191 BEIJING TOPLASER TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 237
12.2 OTHER PLAYERS 239
12.2.1 SYNERON MEDICAL LTD. (A PART OF APAX PARTNERS) 239
12.2.2 AEROLASE 240
12.2.3 BOVIE (A SUBSIDIARY OF SYMMETRY SURGICAL) 240
TABLE 192 SYMMETRY SURGICAL: BUSINESS OVERVIEW 240
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 241
13.1 DISCUSSION GUIDE 241
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 246
13.3 AVAILABLE CUSTOMIZATIONS 248
13.4 RELATED REPORTS 248
13.5 AUTHOR DETAILS 249

　

ページTOPに戻る


　

Summary

The global dermatology devices market is projected to reach USD 11.3 billion by 2027 from USD 6.2 billion in 2022, at a CAGR of 12.7% during the forecasted period. Dermatology devices help dermatologists and surgeons in diagnosing and treating skin disorders. These devices are used by various medical care providers, such as hospitals, dermatology clinics, physician offices, and academic research institutes. The rising incidence of skin diseases and increasing awareness of aesthetic procedures are the primary growth drivers for the dermatology devices market. The expansion of healthcare infrastructure in developing regions is expected to provide growth opportunities to players operating in this market.

“The imaging devices areaccounted to hold the largest share of the dermatology diagnostic devices market, by type in 2021.”
Based on type, the dermatology diagnostic devices market is segmented into imaging devices, dermatoscopes, and microscopes. In 2021, the imaging devices segment accounted for the largest share of the dermatology diagnostic devices market. The large share of this segment can be attributed to technological advancements and the increasing incidence of skin diseases.

“The skin cancer diagnosis are accounted to hold the largest share of the dermatology diagnostic devices market, by application in 2021.”
Based on application, the dermatology diagnostic devices market is segmented into skin cancer diagnosis and other diagnostic applications. In 2021, the skin cancer diagnosis segment accounted for the largest share of the market. The large share of this segment can be attributed to the rising incidence of skin cancer.

“Asia Pacific commanded the highest CAGR of the dermatology devices duringforecasted period.”
Based on region, the dermatology devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. During forecasted period, Asia Pacific has the highest CAGR of the dermatology devices market. The highest CAGR of this regional segment can be attributed to factors such as the large population, rising standards of living, growing demand for quality medical care, increasing healthcare spending, government initiatives, and enhanced awareness about dermatology devices.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%), Tier 2(45%), and Tier 3 (35%)
• By Designation: C-level Executives (30%), Directors (20%), and Others (50%)
• By Region: North America (33%), Europe (24%), AsiaPacific(27%), and Rest of the World (16%)

Some of the major players operating in this market Lumenis Ltd. (Israel),, Alma Lasers, Ltd.(US), Solta Medical (US), and Cutera, Inc.(US)

List of Companies Profiled in the Report
• Alma Lasers, Ltd. (Israel)
• Cutera, Inc. (US)
• Cynosure Inc. (US)
• El.En. S.P.A. (Italy)
• Lumenis Ltd. (Israel)
• Solta Medical (US)
• Bruker Corporation (US)
• Carl Zeiss (Germany)
• HEINE Optotechnik GmbH & Co. KG (Germany)
• Michelson Diagnostics Ltd. (UK)
• PhotoMedex, Inc. (US)
• Leica Microsystems (US)
• Olympus Corporation (Japan)
• Syneron Medical Ltd. (US)
• Genesis Biosystems, Inc. (US)
• Canfield Scientific, Inc. (US)
• Candela (US)
• DermLite (US)
• Beijing Toplaser Technology Co., Ltd. (China)
• Aerolase (US)
• FotoFinder Systems GmbH (Germany)
• Bovie (US)
Research Coverage
This report studies the dermatology devices market based on type, application, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total dermatology devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on dermatology devices offered by the top 22 players in the endoscope reprocessing market. The report analyzes the dermatology devices markettype,application,and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devicesacross key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the dermatology devices market

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the dermatology devices market



ページTOPに戻る


Table of Contents

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS AND EXCLUSIONS 30
1.3 MARKET SCOPE 31
1.3.1 MARKET SEGMENTATION 31
1.3.2 GEOGRAPHIC SCOPE 32
1.3.3 YEARS CONSIDERED 32
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 37
FIGURE 2 PRIMARY SOURCES 37
2.1.2.1 Key data from primary sources 38
2.1.2.2 Key industry insights 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 41
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION 41
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY TREATMENT DEVICES 42
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY DIAGNOSTIC DEVICES 42
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
FIGURE 9 TOP-DOWN APPROACH 44
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 45
FIGURE 10 DATA TRIANGULATION METHODOLOGY 45
2.4 MARKET SHARE ANALYSIS 46
2.5 STUDY ASSUMPTIONS 46
2.6 RISK ASSESSMENT/FACTOR ANALYSIS 47
TABLE 1 RISK ANALYSIS 47
3 EXECUTIVE SUMMARY 48
FIGURE 11 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 12 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 49
FIGURE 13 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 14 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 15 DERMATOLOGY DEVICES MARKET, BY REGION,
2022 VS. 2027 (USD MILLION) 51
4 PREMIUM INSIGHTS 52
4.1 DERMATOLOGY DEVICES MARKET OVERVIEW 52
FIGURE 16 RISING INCIDENCE OF SKIN DISEASES TO DRIVE MARKET GROWTH 52
4.2 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE (2021) 52
FIGURE 17 IMAGING DEVICES SEGMENT DOMINATED APAC MARKET IN 2021 52
4.3 GEOGRAPHICAL SNAPSHOT OF DERMATOLOGY DEVICES MARKET 53
FIGURE 18 JAPAN TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 19 DERMATOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.2.1 DRIVERS 55
5.2.1.1 Rising incidence of skin disorders 55
5.2.1.2 Availability of technologically advanced and user-friendly products 55
5.2.1.3 Growing adoption of minimally invasive and non-invasive aesthetic procedures 56
5.2.1.4 Rising adoption of aesthetic procedures among geriatric individuals 56
FIGURE 20 INCREASE IN GERIATRIC POPULATION, BY COUNTRY
(2011 VS. 2015 VS. 2030) 57
FIGURE 21 INCREASE IN PROPORTION OF GERIATRIC INDIVIDUALS IN OVERALL POPULATION, BY COUNTRY (2011 VS. 2015 VS. 2030) 57
5.2.1.5 Increasing investments, funds, and grants by public-private organizations 57
TABLE 2 KEY INVESTMENTS BY GOVERNMENT BODIES IN THE DIAGNOSTIC IMAGING MARKET 58
5.2.2 RESTRAINTS 59
5.2.2.1 Stringent regulatory policies for medical devices 59
5.2.2.2 Clinical risks and complications associated with dermatology procedures 59
5.2.2.3 High cost of diagnostic imaging systems 59
5.2.2.4 Declining reimbursements and increasing regulatory
burden in the US 60
TABLE 3 MEDICARE REIMBURSEMENT TRENDS, BY IMAGING MODALITY, 2007–2019 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growing medical devices industry in emerging economies 61
FIGURE 22 MEDICAL DEVICES MARKET, 2016–2020 (USD BILLION) 61
5.2.3.2 Increasing disposable income and expanding middle-class population 61
5.2.4 CHALLENGES 62
5.2.4.1 Competitive pricing by low-cost manufacturers and availability of low-cost substitutes 62
5.2.4.2 Dearth of trained professionals 62
5.2.5 TRENDS 63
5.2.5.1 Importance of artificial intelligence and teleradiology in skin disorder diagnosis and treatment 63
5.3 COVID-19 IMPACT ANALYSIS 63
5.4 RANGES/SCENARIOS 64
5.4.1 DERMATOLOGY DEVICES MARKET 64
FIGURE 23 REALISTIC SCENARIO 64
FIGURE 24 PESSIMISTIC SCENARIO 65
FIGURE 25 OPTIMISTIC SCENARIO 65
5.5 REGULATORY ANALYSIS 66
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING DERMATOLOGY DEVICES 66
5.5.1 NORTH AMERICA 66
5.5.1.1 US 66
TABLE 5 US FDA MEDICAL DEVICE CLASSIFICATION 67
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67
5.5.1.2 Canada 68
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68
5.5.2 EUROPE 68
5.5.3 ASIA PACIFIC 68
5.5.3.1 Japan 68
TABLE 8 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY 69
5.5.3.2 China 69
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 69
5.5.3.3 India 70
5.6 PORTER’S FIVE FORCES ANALYSIS 71
5.6.1 THREAT OF NEW ENTRANTS 72
5.6.2 THREAT OF SUBSTITUTES 72
5.6.3 BARGAINING POWER OF SUPPLIERS 72
5.6.4 BARGAINING POWER OF BUYERS 72
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 72
5.7 SUPPLY CHAIN ANALYSIS 73
FIGURE 26 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES 73
5.8 VALUE CHAIN ANALYSIS 74
FIGURE 27 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 74
5.9 ECOSYSTEM ANALYSIS 75
FIGURE 28 DERMATOLOGY DEVICES MARKET: ECOSYSTEM ANALYSIS 75
5.9.1 ROLE IN ECOSYSTEM 75
FIGURE 29 KEY PLAYERS IN DERMATOLOGY DEVICES MARKET ECOSYSTEM 76
5.10 TECHNOLOGY ANALYSIS 76
5.11 KEY CONFERENCES & EVENTS IN 2022–2023 77
TABLE 10 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF
CONFERENCES & EVENTS 77
5.12 PATENT ANALYSIS 82
5.12.1 PATENT TRENDS FOR DERMATOLOGY DEVICES 82
FIGURE 30 PATENT TRENDS FOR DERMATOSCOPES, JANUARY 2011–JUNE 2022 82
FIGURE 31 PATENT TRENDS FOR LIPOSUCTION DEVICES, JANUARY 2011–JUNE 2022 83
5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS 83
FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS)
FOR DERMATOSCOPE PATENTS, JANUARY 2011—JUNE 2022 84
FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS)
FOR LIPOSUCTION DEVICE PATENTS, JANUARY 2011—JUNE 2022 84
5.13 TRADE ANALYSIS 85
TABLE 11 IMPORT DATA FOR HS CODE 901320, BY COUNTRY,
2017–2021 (USD MILLION) 85
TABLE 12 EXPORT DATA FOR HS CODE 901320, BY COUNTRY,
2017–2021 (USD MILLION) 85
5.14 PRICING ANALYSIS 86
TABLE 13 AVERAGE SELLING PRICES OF DERMATOLOGY DEVICES 86
TABLE 14 COST OF DERMATOLOGY TREATMENT DEVICES 86
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 90
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
FIGURE 34 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES 90
TABLE 15 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES (%) 90
5.15.2 BUYING CRITERIA 91
FIGURE 35 KEY BUYING CRITERIA FOR END USERS OF
DERMATOLOGY TREATMENT DEVICES 91
TABLE 16 KEY BUYING CRITERIA FOR END USERS OF
DERMATOLOGY TREATMENT DEVICES 91
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS 92
5.16.1 REVENUE SHIFT & REVENUE POCKETS FOR DERMATOLOGY DEVICE MANUFACTURERS 92
FIGURE 36 REVENUE SHIFT FOR DERMATOLOGY DEVICES 92
6 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE 93
6.1 INTRODUCTION 94
TABLE 17 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 94
6.2 IMAGING DEVICES 94
6.2.1 MRI, ULTRASOUND, CT, AND OCT ARE WIDELY USED IN DERMATOLOGY DISEASE DIAGNOSIS 94
TABLE 18 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR IMAGING DEVICES,
BY REGION, 2020–2027 (USD MILLION) 95
6.3 DERMATOSCOPES 95
6.3.1 INCREASING AWARENESS ABOUT SKIN HEALTH TO DRIVE SEGMENT GROWTH 95
TABLE 19 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR DERMATOSCOPES,
BY REGION, 2020–2027 (USD MILLION) 96
6.4 MICROSCOPES 96
6.4.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED MICROSCOPES —
A KEY FACTOR DRIVING SEGMENT GROWTH 96
TABLE 20 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR MICROSCOPES,
BY REGION, 2020–2027 (USD MILLION) 97
7 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION 98
7.1 INTRODUCTION 99
TABLE 21 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 99
7.2 SKIN CANCER DIAGNOSIS 99
7.2.1 RISING PREVALENCE OF SKIN CANCER AND INCREASING AWARENESS ABOUT EARLY DIAGNOSIS TO DRIVE SEGMENT GROWTH 99
TABLE 22 NUMBER OF MELANOMA SKIN CANCER CASES, BY COUNTRY (2020) 100
TABLE 23 NUMBER OF NON-MELANOMA SKIN CANCER CASES, BY COUNTRY (2020) 100
TABLE 24 NUMBER OF MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020) 101
TABLE 25 NUMBER OF NON-MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020) 101
TABLE 26 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR SKIN CANCER DIAGNOSIS, BY REGION, 2020–2027 (USD MILLION) 102
7.3 OTHER DIAGNOSTIC APPLICATIONS 102
TABLE 27 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 102
8 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE 103
8.1 INTRODUCTION 104
TABLE 28 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 104
8.2 LIGHT THERAPY DEVICES 104
8.2.1 INCREASING DEMAND FOR SKIN REJUVENATION PROCEDURES
TO DRIVE SEGMENT GROWTH 104
TABLE 29 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIGHT THERAPY DEVICES, BY REGION, 2020–2027 (USD MILLION) 105
8.3 LASERS 105
8.3.1 IMPROVING LASER TECHNOLOGY HAS REVOLUTIONIZED TREATMENTS FOR SEVERAL SKIN CONDITIONS 105
TABLE 30 DERMATOLOGY TREATMENT DEVICES MARKET FOR LASERS, BY REGION, 2020–2027 (USD MILLION) 106
8.4 ELECTROSURGICAL EQUIPMENT 106
8.4.1 RISK OF ELECTROSURGICAL BURNS IS EXPECTED TO HINDER SEGMENT GROWTH 106
TABLE 31 DERMATOLOGY TREATMENT DEVICES MARKET FOR ELECTROSURGICAL EQUIPMENT, BY REGION, 2020–2027 (USD MILLION) 107
8.5 LIPOSUCTION DEVICES 107
8.5.1 INCREASING OBESITY RATES TO DRIVE SEGMENT GROWTH 107
TABLE 32 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIPOSUCTION DEVICES, BY REGION, 2020–2027 (USD MILLION) 107
8.6 MICRODERMABRASION DEVICES 108
8.6.1 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH 108
TABLE 33 DERMATOLOGY TREATMENT DEVICES MARKET FOR MICRODERMABRASION DEVICES, BY REGION, 2020–2027 (USD MILLION) 108
8.7 CRYOTHERAPY DEVICES 108
8.7.1 COST-EFFECTIVE NATURE OF CRYOTHERAPY TO DRIVE ITS ADOPTION 108
TABLE 34 DERMATOLOGY TREATMENT DEVICES MARKET FOR CRYOTHERAPY DEVICES, BY REGION, 2020–2027 (USD MILLION) 109
9 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION 110
9.1 INTRODUCTION 111
TABLE 35 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 111
9.2 HAIR REMOVAL 111
9.2.1 IPL, DIODE, ND:YAG, AND RUBY LASERS ARE WIDELY USED IN HAIR REMOVAL PROCEDURES 111
TABLE 36 LASER HAIR REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020) 112
TABLE 37 DERMATOLOGY TREATMENT DEVICES MARKET FOR HAIR REMOVAL,
BY REGION, 2020–2027 (USD MILLION) 112
9.3 SKIN REJUVENATION 112
9.3.1 GROWING DEMAND FOR SAFE AND EFFECTIVE SKIN REJUVENATION TREATMENTS TO PROPEL SEGMENT GROWTH 112
TABLE 38 DERMATOLOGY TREATMENT DEVICES MARKET FOR SKIN REJUVENATION,
BY REGION, 2020–2027 (USD MILLION) 113
9.4 ACNE, PSORIASIS, AND TATTOO REMOVAL 113
9.4.1 EMERGENCE OF LASER TECHNOLOGY FOR TATTOO REMOVAL TO DRIVE SEGMENT GROWTH 113
TABLE 39 LASER TATTOO REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020) 114
TABLE 40 DERMATOLOGY TREATMENT DEVICES MARKET FOR ACNE, PSORIASIS, AND TATTOO REMOVAL, BY REGION, 2020–2027 (USD MILLION) 114
9.5 WRINKLE REMOVAL AND SKIN RESURFACING 115
9.5.1 RAPIDLY GROWING AGING POPULATION TO DRIVE SEGMENT GROWTH 115
TABLE 41 SKIN RESURFACING PROCEDURES: REGIONAL DISTRIBUTION (2020) 115
TABLE 42 DERMATOLOGY TREATMENT DEVICES MARKET FOR WRINKLE REMOVAL AND SKIN RESURFACING, BY REGION, 2020–2027 (USD MILLION) 116
9.6 BODY CONTOURING AND FAT REMOVAL 116
9.6.1 RISING AWARENESS OF RECONSTRUCTIVE SURGERY
TO DRIVE SEGMENT GROWTH 116
TABLE 43 LIPOSUCTION PROCEDURES: REGIONAL DISTRIBUTION (2020) 117
TABLE 44 NON-INVASIVE FAT REDUCTION (COOLSCULPTING, LIPOSONIX, EMSCULPT, VANQUISH, AND ZERONA) PROCEDURES: REGIONAL DISTRIBUTION (2020) 117
TABLE 45 DERMATOLOGY TREATMENT DEVICES MARKET FOR BODY CONTOURING AND FAT REMOVAL, BY REGION, 2020–2027 (USD MILLION) 118
9.7 VASCULAR AND PIGMENTED LESION REMOVAL 118
9.7.1 EMERGENCE OF LASER TECHNOLOGY FOR VASCULAR LESION REMOVAL TO DRIVE SEGMENT GROWTH 118
TABLE 46 DERMATOLOGY TREATMENT DEVICES MARKET FOR VASCULAR AND PIGMENTED LESION REMOVAL, BY REGION, 2020–2027 (USD MILLION) 118
9.8 WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT 119
9.8.1 CRYOTHERAPY IS WIDELY USED IN WART AND SKIN TAG TREATMENT 119
TABLE 47 DERMATOLOGY TREATMENT DEVICES MARKET FOR WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT, BY REGION, 2020–2027 (USD MILLION) 119
9.9 OTHER TREATMENT APPLICATIONS 119
TABLE 48 DERMATOLOGY TREATMENT DEVICES MARKET FOR OTHER APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION) 119
10 DERMATOLOGY DEVICES MARKET, BY REGION 120
10.1 INTRODUCTION 121
TABLE 49 DERMATOLOGY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 121
10.2 NORTH AMERICA 121
FIGURE 37 NORTH AMERICA: DERMATOLOGY DEVICES MARKET SNAPSHOT 122
TABLE 50 NORTH AMERICA: DERMATOLOGY DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 123
TABLE 51 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 52 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 53 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 54 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 124
10.2.1 US 124
10.2.1.1 US dominated North American market in 2021 124
TABLE 55 US: KEY MACROINDICATORS 125
TABLE 56 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 125
TABLE 57 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 125
TABLE 58 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 126
TABLE 59 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 126
TABLE 60 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 126
TABLE 61 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 62 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 127
TABLE 63 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 127
10.2.2 CANADA 128
10.2.2.1 Technological advancements in dermatology devices to drive market growth in Canada 128
TABLE 64 CANADA: KEY MACROINDICATORS 128
TABLE 65 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 66 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 67 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 129
TABLE 68 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 129
10.3 EUROPE 130
TABLE 69 EUROPE: DERMATOLOGY DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 130
TABLE 70 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 71 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 131
TABLE 72 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 73 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
10.3.1 FRANCE 132
10.3.1.1 Laws in France regarding cosmetic surgery are restrictive as compared with those in other countries 132
TABLE 74 FRANCE: KEY MACROINDICATORS 132
TABLE 75 FRANCE: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 132
TABLE 76 FRANCE: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 133
TABLE 77 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 133
TABLE 78 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 133
TABLE 79 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 134
TABLE 80 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 134
10.3.2 GERMANY 134
10.3.2.1 Rising disposable income to drive dermatology device adoption in Germany 134
TABLE 81 GERMANY: KEY MACROINDICATORS 135
TABLE 82 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 135
TABLE 83 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 135
TABLE 84 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 136
TABLE 85 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 136
TABLE 86 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 136
TABLE 87 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 137
TABLE 88 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 137
TABLE 89 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 137
10.3.3 UK 138
10.3.3.1 Increasing focus on facial dermatology to aid market growth 138
TABLE 90 UK: KEY MACROINDICATORS 138
TABLE 91 UK: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 138
TABLE 92 UK: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 138
TABLE 93 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 139
TABLE 94 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 139
TABLE 95 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 139
TABLE 96 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 140
10.3.4 ITALY 140
10.3.4.1 Rising number of plastic surgeons to drive market growth 140
TABLE 97 ITALY: KEY MACROINDICATORS 140
TABLE 98 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 141
TABLE 99 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 141
TABLE 100 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 141
TABLE 101 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 141
TABLE 102 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 142
TABLE 103 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 142
TABLE 104 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 105 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 143
10.3.5 SPAIN 143
10.3.5.1 Growing demand for cosmetic procedures to drive market growth 143
TABLE 106 SPAIN: KEY MACROINDICATORS 144
TABLE 107 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 144
TABLE 108 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 144
TABLE 109 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 145
TABLE 110 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 145
TABLE 111 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 145
TABLE 112 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 146
TABLE 113 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 146
TABLE 114 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147
10.3.6 REST OF EUROPE 147
TABLE 115 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP) 148
TABLE 116 RUSSIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 148
TABLE 117 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 118 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 119 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 149
TABLE 120 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 150
10.4 ASIA PACIFIC 150
FIGURE 38 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET SNAPSHOT 151
TABLE 121 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 152
TABLE 122 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 123 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 124 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 153
TABLE 125 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 153
10.4.1 JAPAN 153
10.4.1.1 Japan accounted for largest share of APAC market in 2021 153
TABLE 126 JAPAN: KEY MACROINDICATORS 154
TABLE 127 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 154
TABLE 128 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 154
TABLE 129 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 155
TABLE 130 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 155
TABLE 131 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 155
TABLE 132 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 156
TABLE 133 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 156
TABLE 134 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 156
10.4.2 CHINA 157
10.4.2.1 Rising healthcare expenditure to drive market growth in China 157
TABLE 135 CHINA: KEY MACROINDICATORS 157
TABLE 136 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 137 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 158
TABLE 138 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 139 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
10.4.3 INDIA 159
10.4.3.1 Improving healthcare infrastructure to drive market growth in India 159
TABLE 140 INDIA: KEY MACROINDICATORS 159
TABLE 141 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 159
TABLE 142 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2019 160
TABLE 143 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020 160
TABLE 144 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019 160
TABLE 145 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 146 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 147 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 161
TABLE 148 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
10.4.4 REST OF ASIA PACIFIC 162
TABLE 149 THAILAND: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 163
TABLE 150 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 163
TABLE 151 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 163
TABLE 152 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 164
TABLE 153 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 164
10.5 REST OF THE WORLD 164
TABLE 154 MEXICO: KEY MACROINDICATORS 165
TABLE 155 BRAZIL: KEY MACROINDICATORS 165
TABLE 156 BRAZIL: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 165
TABLE 157 MEXICO: LEADING COSMETIC SURGICAL PROCEDURES IN 2020 165
TABLE 158 ROW: DERMATOLOGY DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 166
TABLE 159 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 166
TABLE 160 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 166
TABLE 161 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 167
TABLE 162 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 167
11 COMPETITIVE LANDSCAPE 168
11.1 OVERVIEW 168
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 168
TABLE 163 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS 168
11.3 REVENUE ANALYSIS 170
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN DERMATOLOGY TREATMENT DEVICES MARKET 170
11.4 MARKET SHARE ANALYSIS 170
FIGURE 40 DERMATOLOGY TREATMENT DEVICES MARKET SHARE ANALYSIS, 2020 171
TABLE 164 DERMATOLOGY TREATMENT DEVICES MARKET: DEGREE OF COMPETITION 171
11.5 COMPANY EVALUATION MATRIX (KEY PLAYERS) 172
11.5.1 STARS 172
11.5.2 EMERGING LEADERS 172
11.5.3 PARTICIPANTS 173
11.5.4 PERVASIVE PLAYERS 173
FIGURE 41 GLOBAL DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 173
11.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES) 174
11.6.1 PROGRESSIVE COMPANIES 174
11.6.2 STARTING BLOCKS 174
11.6.3 RESPONSIVE COMPANIES 174
11.6.4 DYNAMIC COMPANIES 174
FIGURE 42 DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2021 175
11.7 COMPETITIVE BENCHMARKING 176
TABLE 165 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF KEY SMES/START-UPS 176
TABLE 166 DERMATOLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF SMES/START-UPS 177
11.8 COMPANY FOOTPRINT 177
TABLE 167 OVERALL FOOTPRINT OF COMPANIES 178
TABLE 168 PRODUCT FOOTPRINT OF COMPANIES 179
TABLE 169 REGIONAL FOOTPRINT OF COMPANIES 180
11.9 COMPETITIVE SCENARIO AND TRENDS 181
11.9.1 DEALS 181
TABLE 170 DEALS, JANUARY 2019–MAY 2022 181
11.9.2 PRODUCT LAUNCHES & APPROVALS 182
TABLE 171 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MAY 2022 182
11.9.3 EXPANSIONS 184
TABLE 172 EXPANSIONS, JANUARY 2019–MAY 2022 184
12 COMPANY PROFILES 185
12.1 KEY PLAYERS 185
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 ALMA LASERS, LTD. (A SUBSIDIARY OF SISRAM MEDICAL LTD.) 185
TABLE 173 ALMA LASERS, LTD.: BUSINESS OVERVIEW 185
FIGURE 43 SISRAM MEDICAL LTD.: COMPANY SNAPSHOT (2021) 186
12.1.2 CUTERA, INC. 191
TABLE 174 CUTERA, INC.: BUSINESS OVERVIEW 191
FIGURE 44 CUTERA, INC.: COMPANY SNAPSHOT (2021) 192
12.1.3 CYNOSURE, INC. 196
TABLE 175 CYNOSURE, INC.: BUSINESS OVERVIEW 196
12.1.4 EL.EN. S.P.A. 199
TABLE 176 EL.EN. S.P.A.: BUSINESS OVERVIEW 199
FIGURE 45 EL.EN. S.P.A.: COMPANY SNAPSHOT (2021) 200
12.1.5 LUMENIS, LTD. (A SUBSIDIARY OF BOSTON SCIENTIFIC) 203
TABLE 177 LUMENIS, LTD.: BUSINESS OVERVIEW 203
FIGURE 46 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2021) 204
12.1.6 SOLTA MEDICAL (A SUBSIDIARY OF BAUSCH HEALTH COMPANIES INC.) 208
TABLE 178 SOLTA MEDICAL: BUSINESS OVERVIEW 208
FIGURE 47 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2021) 209
12.1.7 DERMLITE 212
TABLE 179 DERMLITE: BUSINESS OVERVIEW 212
12.1.8 BRUKER CORPORATION 213
TABLE 180 BRUKER CORPORATION: BUSINESS OVERVIEW 213
FIGURE 48 BRUKER CORPORATION: COMPANY SNAPSHOT (2021) 214
12.1.9 CARL ZEISS 215
TABLE 181 CARL ZEISS: BUSINESS OVERVIEW 215
FIGURE 49 CARL ZEISS: COMPANY SNAPSHOT (2021) 216
12.1.10 GENESIS BIOSYSTEMS, INC. 218
TABLE 182 GENESIS BIOSYSTEMS, INC.: BUSINESS OVERVIEW 218
12.1.11 HEINE OPTOTECHNIK GMBH & CO. KG 219
TABLE 183 HEINE OPTOTECHNIK GMBH & CO. KG: BUSINESS OVERVIEW 219
12.1.12 MICHELSON DIAGNOSTICS, LTD. 221
TABLE 184 MICHELSON DIAGNOSTICS, LTD.: BUSINESS OVERVIEW 221
12.1.13 PHOTOMEDEX, INC. (A SUBSIDIARY OF DS HEALTHCARE GROUP) 223
TABLE 185 PHOTOMEDEX, INC.: BUSINESS OVERVIEW 223
12.1.14 FOTOFINDER SYSTEMS GMBH 224
TABLE 186 FOTOFINDER SYSTEMS GMBH: BUSINESS OVERVIEW 224
12.1.15 LEICA MICROSYSTEMS (A SUBSIDIARY OF DANAHER CORPORATION) 225
TABLE 187 LEICA MICROSYSTEMS: BUSINESS OVERVIEW 225
FIGURE 50 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 226
12.1.16 OLYMPUS CORPORATION 228
TABLE 188 OLYMPUS CORPORATION: BUSINESS OVERVIEW 228
FIGURE 51 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021) 229
12.1.17 CANDELA CORPORATION 231
TABLE 189 CANDELA CORPORATION: BUSINESS OVERVIEW 231
FIGURE 52 CANDELA CORPORATION: COMPANY SNAPSHOT (2020) 231
12.1.18 CANFIELD SCIENTIFIC, INC. 235
TABLE 190 CANFIELD SCIENTIFIC, INC.: BUSINESS OVERVIEW 235
12.1.19 BEIJING TOPLASER TECHNOLOGY CO., LTD. 237
TABLE 191 BEIJING TOPLASER TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 237
12.2 OTHER PLAYERS 239
12.2.1 SYNERON MEDICAL LTD. (A PART OF APAX PARTNERS) 239
12.2.2 AEROLASE 240
12.2.3 BOVIE (A SUBSIDIARY OF SYMMETRY SURGICAL) 240
TABLE 192 SYMMETRY SURGICAL: BUSINESS OVERVIEW 240
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 241
13.1 DISCUSSION GUIDE 241
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 246
13.3 AVAILABLE CUSTOMIZATIONS 248
13.4 RELATED REPORTS 248
13.5 AUTHOR DETAILS 249

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（薬学的薬物）の最新刊レポート

MarketsandMarkets社のその他分野での最新刊レポート

本レポートと同じKEY WORD（dermatology）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.